These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 9072007)

  • 1. Galectin-3 and laminin expression in neoplastic and non-neoplastic thyroid tissue.
    Fernández PL; Merino MJ; Gómez M; Campo E; Medina T; Castronovo V; Sanjuán X; Cardesa A; Liu FT; Sobel ME
    J Pathol; 1997 Jan; 181(1):80-6. PubMed ID: 9072007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of galectin-3 in fine-needle aspirates as a diagnostic marker differentiating benign from malignant thyroid neoplasms.
    Inohara H; Honjo Y; Yoshii T; Akahani S; Yoshida J; Hattori K; Okamoto S; Sawada T; Raz A; Kubo T
    Cancer; 1999 Jun; 85(11):2475-84. PubMed ID: 10357421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical localization of galectin-3 in malignant and benign human thyroid tissue.
    Cvejic D; Savin S; Paunovic I; Tatic S; Havelka M; Sinadinovic J
    Anticancer Res; 1998; 18(4A):2637-41. PubMed ID: 9703921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic utility of galectin-3 and CD26/DPPIV as preoperative diagnostic markers for thyroid nodules.
    Aratake Y; Umeki K; Kiyoyama K; Hinoura Y; Sato S; Ohno A; Kuribayashi T; Hirai K; Nabeshima K; Kotani T
    Diagn Cytopathol; 2002 Jun; 26(6):366-72. PubMed ID: 12112826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of galectin 3 expression in thyroid aspirates as a diagnostic marker in differentiating benign from malignant thyroid neoplasms.
    Aron M; Kapila K; Verma K
    Indian J Pathol Microbiol; 2006 Jul; 49(3):376-80. PubMed ID: 17001889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Galectin-3 does not reliably distinguish benign from malignant thyroid neoplasms.
    Mehrotra P; Okpokam A; Bouhaidar R; Johnson SJ; Wilson JA; Davies BR; Lennard TW
    Histopathology; 2004 Nov; 45(5):493-500. PubMed ID: 15500653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Galectin-3 is a presurgical marker of human thyroid carcinoma.
    Orlandi F; Saggiorato E; Pivano G; Puligheddu B; Termine A; Cappia S; De Giuli P; Angeli A
    Cancer Res; 1998 Jul; 58(14):3015-20. PubMed ID: 9679965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential expression of galectin-1 and galectin-3 in thyroid tumors. Potential diagnostic implications.
    Xu XC; el-Naggar AK; Lotan R
    Am J Pathol; 1995 Sep; 147(3):815-22. PubMed ID: 7677193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of ras oncogene p21 antigen in normal and proliferative thyroid tissues.
    Johnson TL; Lloyd RV; Thor A
    Am J Pathol; 1987 Apr; 127(1):60-5. PubMed ID: 3105323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patterns of basement membrane laminin distribution in nonneoplastic and neoplastic thyroid tissue.
    Campo E; Perez M; Charonis AA; Axiotis CA; Merino MJ
    Mod Pathol; 1992 Sep; 5(5):540-6. PubMed ID: 1344818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of galectin-3 immunohistochemistry in differential diagnosis between thyroid follicular carcinoma and follicular adenoma.
    Jakubiak-Wielganowicz M; Kubiak R; Sygut J; Pomorski L; Kordek R
    Pol J Pathol; 2003; 54(2):111-5. PubMed ID: 14575419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thyroid peroxidase and galectin-3 immunostaining in differentiated thyroid carcinoma with clinicopathologic correlation.
    Savin S; Cvejic D; Isic T; Paunovic I; Tatic S; Havelka M
    Hum Pathol; 2008 Nov; 39(11):1656-63. PubMed ID: 18657294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Galectin-3 expression in various thyroid neoplasms and its possible role in metastasis formation.
    Kawachi K; Matsushita Y; Yonezawa S; Nakano S; Shirao K; Natsugoe S; Sueyoshi K; Aikou T; Sato E
    Hum Pathol; 2000 Apr; 31(4):428-33. PubMed ID: 10821488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of Galectin-3 and Galectin-7 in thyroid malignancy as potential diagnostic indicators.
    Than TH; Swethadri GK; Wong J; Ahmad T; Jamil D; Maganlal RK; Hamdi MM; Abdullah MS
    Singapore Med J; 2008 Apr; 49(4):333-8. PubMed ID: 18418527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical loss of thyroid peroxidase in papillary thyroid carcinoma: strong suppression of peroxidase gene expression.
    Tanaka T; Umeki K; Yamamoto I; Sugiyama S; Noguchi S; Ohtaki S
    J Pathol; 1996 May; 179(1):89-94. PubMed ID: 8691351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of HBME-1, cytokeratin 19 and galectin-3 immunostaining in the diagnosis of thyroid malignancy.
    de Matos PS; Ferreira AP; de Oliveira Facuri F; Assumpção LV; Metze K; Ward LS
    Histopathology; 2005 Oct; 47(4):391-401. PubMed ID: 16178894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thyroid transcription factor-1 in normal, hyperplastic, and neoplastic follicular thyroid cells examined by immunohistochemistry and nonradioactive in situ hybridization.
    Katoh R; Kawaoi A; Miyagi E; Li X; Suzuki K; Nakamura Y; Kakudo K
    Mod Pathol; 2000 May; 13(5):570-6. PubMed ID: 10824930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [CD26/dipeptidyl peptidase IV and thyroid peroxidase as molecular markers for differentiated thyroid carcinoma].
    Umeki K; Yamamoto I; Maruta J; Aratake Y; Ono I; Uemura Y; Tanaka T; Toyoda K; Kotani T; Noguchi S; Sakamoto F; Konoe K; Ohtaki S
    Rinsho Byori; 1996 Jan; 44(1):42-50. PubMed ID: 8691639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of galectin-3 in normal and malignant thyroid tissue by quantitative PCR and immunohistochemistry.
    Feilchenfeldt J; Tötsch M; Sheu SY; Robert J; Spiliopoulos A; Frilling A; Schmid KW; Meier CA
    Mod Pathol; 2003 Nov; 16(11):1117-23. PubMed ID: 14614051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Galectin-3 is not useful in thyroid FNA.
    Mills LJ; Poller DN; Yiangou C
    Cytopathology; 2005 Jun; 16(3):132-8. PubMed ID: 15924608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.